Unraveling microglial spatial organization in the developing human brain with DeepCellMap, a deep learning approach coupled with spatial statistics.

Publication date: Feb 13, 2025

Mapping cellular organization in the developing brain presents significant challenges due to the multidimensional nature of the data, characterized by complex spatial patterns that are difficult to interpret without high-throughput tools. Here, we present DeepCellMap, a deep-learning-assisted tool that integrates multi-scale image processing with advanced spatial and clustering statistics. This pipeline is designed to map microglial organization during normal and pathological brain development and has the potential to be adapted to any cell type. Using DeepCellMap, we capture the morphological diversity of microglia, identify strong coupling between proliferative and phagocytic phenotypes, and show that distinct spatial clusters rarely overlap as human brain development progresses. Additionally, we uncover an association between microglia and blood vessels in fetal brains exposed to maternal SARS-CoV-2. These findings offer insights into whether various microglial phenotypes form networks in the developing brain to occupy space, and in conditions involving haemorrhages, whether microglia respond to, or influence changes in blood vessel integrity. DeepCellMap is available as an open-source software and is a powerful tool for extracting spatial statistics and analyzing cellular organization in large tissue sections, accommodating various imaging modalities. This platform opens new avenues for studying brain development and related pathologies.

Open Access PDF

Concepts Keywords
Deepcellmap Blood
Haemorrhages Brain
Learning Cellular
Powerful Deep
Tools Deepcellmap
Developing
Imaging
Learning
Microglia
Microglial
Organization
Phenotypes
Spatial
Statistics
Unraveling

Semantics

Type Source Name
disease IDO cell
drug DRUGBANK Trestolone
drug DRUGBANK Esomeprazole
disease MESH hemorrhages
disease MESH tumor
drug DRUGBANK Coenzyme M
disease IDO process
disease IDO algorithm
disease IDO object
disease MESH Uncertainty
disease MESH confusion
pathway REACTOME Apoptosis
disease MESH death
drug DRUGBANK Flunarizine
drug DRUGBANK Ademetionine
drug DRUGBANK Cysteamine
disease MESH COVID19
drug DRUGBANK Sulodexide
disease MESH congenital abnormalities
disease MESH genetic disorders
disease MESH periventricular leukomalacia
disease MESH infection
drug DRUGBANK Aminosalicylic Acid
drug DRUGBANK Formaldehyde
drug DRUGBANK Ethanol
drug DRUGBANK Citric Acid
drug DRUGBANK Hydrogen peroxide
drug DRUGBANK Alkaline Phosphatase
drug DRUGBANK Phosphate ion
drug DRUGBANK Sucrose
drug DRUGBANK Aspartame

Original Article

(Visited 1 times, 1 visits today)